@misc{wang_streptamer_versus_2013, 
author={Wang, X.-C., Pang, H., Xu, X., Schmitt, A., Freund, M., Schmitt, M., Chen, B.-A.},
title={Streptamer versus tetramer-based selection of functional cytomegalovirus-specific T cells},
year={2013},
howpublished = {journal article},
doi = {https://doi.org/10.1016/j.jfma.2012.02.020},
abstract = {Our study demonstrated that both tetra- and streptamer technologies can be used to purify CMV-specific cytotoxic CD8+ T cells for adoptive T-cell transfer. Both multimer technologies did not have any negative influence on the proliferation of selected T cells. Importantly, streptamer technology is available at good manufacturing practice level.},
note = {Online available at: \url{https://doi.org/10.1016/j.jfma.2012.02.020} (DOI). Wang, X.; Pang, H.; Xu, X.; Schmitt, A.; Freund, M.; Schmitt, M.; Chen, B.: Streptamer versus tetramer-based selection of functional cytomegalovirus-specific T cells. Journal of the Formosan Medical Association. 2013. vol. 112, no. 6, 338-345. DOI: 10.1016/j.jfma.2012.02.020}}